Evoke Pharma Cash Flow - Quarterly (NASDAQ:EVOK)

Add to My Stocks
$3.33 $0.09 (2.78%) EVOK stock closing price Sep 17, 2018 (Closing)

The Evoke Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Evoke Pharma profits and Evoke Pharma debt. Evoke Pharma saw a cash impact of $3.43M from the issuance of EVOK shares. The cash flow statement helps in the Evoke Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. EVOK decrease in investments stood at a value of $- for the latest quarter 2018 Q2.

View and download details of Evoke Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-4.29M-1.98M-12.22M-11.92M-6.67M-5.05M-10.74M-9.22M-6.19M-3.22M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.64M-0.79M-1.17M--0.17M--0.26M--
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--0.03M2.82M4.75M2.73M3.53M1.76M2.15M--
Net Cash from (used by) Operating Activities
-4.58M-2.81M-8.71M-5.98M-3.78M-1.68M-8.7M-7.33M-4.92M-2.69M
Increase (Decrease) in Prop Plant And Equipment----------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
----------
Issuance (Purchase) of Equity Shares3.43M-7.38M7.38M7.33M7.33M13.52M13.52M--
Issuance (Repayment) of Debt Securities-------4.5M-4.5M--
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
3.43M-7.38M7.38M7.33M7.33M9.02M9.02M--
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-1.15M-2.27M-1.32M1.4M3.54M5.64M-1.68M-4.56M-2.59M
Cash & Equivalents at Beginning of Year7.68M9M8.69M14.15M24.19M--4.03M--
Cash & Equivalents at Year End6.53M5.4M7.67M10.41M12.55M14.65M9M10.37M4.12M6.09M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Evoke Pharma stock price history provides the price history of a stock, Evoke Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Evoke Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Evoke Pharma stock price movement.
  • Cash Flow from operating activities: Evoke Pharma reported a negative operating cash flow of $-4.58M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for EVOK till last quarter 2018 Q2 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $3.43M for Evoke Pharma.

Key Financial Ratios For Evoke Pharma Cash Flow